Correlation Between Upstream Bio, and Aptevo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Upstream Bio, and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Upstream Bio, and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Upstream Bio, and Aptevo Therapeutics, you can compare the effects of market volatilities on Upstream Bio, and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Upstream Bio, with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Upstream Bio, and Aptevo Therapeutics.
Diversification Opportunities for Upstream Bio, and Aptevo Therapeutics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Upstream and Aptevo is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Upstream Bio, and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Upstream Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Upstream Bio, are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Upstream Bio, i.e., Upstream Bio, and Aptevo Therapeutics go up and down completely randomly.
Pair Corralation between Upstream Bio, and Aptevo Therapeutics
Considering the 90-day investment horizon Upstream Bio, is expected to generate 0.62 times more return on investment than Aptevo Therapeutics. However, Upstream Bio, is 1.62 times less risky than Aptevo Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Aptevo Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 1,636 in Upstream Bio, on August 20, 2025 and sell it today you would earn a total of 934.00 from holding Upstream Bio, or generate 57.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Upstream Bio, vs. Aptevo Therapeutics
Performance |
| Timeline |
| Upstream Bio, |
| Aptevo Therapeutics |
Upstream Bio, and Aptevo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Upstream Bio, and Aptevo Therapeutics
The main advantage of trading using opposite Upstream Bio, and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Upstream Bio, position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.| Upstream Bio, vs. Zenas BioPharma, Common | Upstream Bio, vs. Intellia Therapeutics | Upstream Bio, vs. Wave Life Sciences | Upstream Bio, vs. Relay Therapeutics |
| Aptevo Therapeutics vs. Kiora Pharmaceuticals | Aptevo Therapeutics vs. HCW Biologics | Aptevo Therapeutics vs. ABPRO P | Aptevo Therapeutics vs. Matinas BioPharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |